People

Hendrik P.N. Scholl

Hendrik P.N. Scholl

Hendrik P.N. Scholl is named Investment Advisory Board in Droia’s current public directory. The published professional background includes M.D. University of Tübingen; Professor and Chairman of the Department of Ophthalmology, University of Basel; Founding and Scientific Director of the Institute of Molecular and Clinical Ophthalmology Basel (IOB); Retinal specialist with expertise in translational research in ophthalmology, especially gene therapy. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.

Roles

Droia Ventures

Investment Advisory Board

Current